MCID: VGN019
MIFTS: 34

Vaginal Discharge

Categories: Reproductive diseases

Aliases & Classifications for Vaginal Discharge

MalaCards integrated aliases for Vaginal Discharge:

Name: Vaginal Discharge 12 45 15 17

Classifications:



External Ids:

Disease Ontology 12 DOID:3767
MeSH 45 D019522
NCIt 51 C50795
SNOMED-CT 69 70856007
UMLS 74 C0227791

Summaries for Vaginal Discharge

Disease Ontology : 12 A vaginal disease that is characterized by the presence of discharge.

MalaCards based summary : Vaginal Discharge is related to endometritis and bacterial vaginosis. An important gene associated with Vaginal Discharge is DSPP (Dentin Sialophosphoprotein). The drugs Metronidazole and Iodine have been mentioned in the context of this disorder. Affiliated tissues include cervix, testes and skin.

Wikipedia : 77 Vaginal discharge is a mixture of liquid, cells, and bacteria that lubricates and protects the vagina.... more...

Related Diseases for Vaginal Discharge

Diseases related to Vaginal Discharge via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 59)
# Related Disease Score Top Affiliating Genes
1 endometritis 30.3 HP PGF
2 bacterial vaginosis 11.7
3 pelvic inflammatory disease 11.6
4 vaginitis 11.6
5 leukorrhea 11.6
6 trichomoniasis 11.5
7 chlamydia 11.5
8 trichomonas vaginalis trichomoniasis 11.2
9 fallopian tube carcinoma 11.2
10 vulvovaginal candidiasis 11.2
11 uterine carcinosarcoma 11.2
12 fitz-hugh-curtis syndrome 11.2
13 anhaptoglobinemia 10.1 HP TXNL4B
14 retinitis pigmentosa, y-linked 10.0 GYPC HPSE2
15 candidiasis 10.0
16 vulvovaginitis 10.0
17 endometrial disease 10.0 DSPP HP PGF
18 fallopian tube disease 10.0 EXTL3 MAPK8IP1
19 radiation cystitis 9.9 MAPK8IP1 PGF
20 vaginal disease 9.9 EXTL3 HP SPTB
21 hereditary elliptocytosis 9.9 GYPC SPTB
22 uterine anomalies 9.8 HPSE2 MAPK8IP1
23 congenital hemolytic anemia 9.8 HP SPTB
24 breast cancer 9.8
25 hypercarotenemia and vitamin a deficiency, autosomal dominant 9.8
26 klippel-trenaunay-weber syndrome 9.8
27 pemphigus vulgaris, familial 9.8
28 renal hypodysplasia/aplasia 1 9.8
29 uterus bicornis bicollis with partial vaginal septum and unilateral hematocolpos with ipsilateral renal agenesis 9.8
30 adenomyosis 9.8
31 cervical cancer 9.8
32 lymphangioleiomyomatosis 9.8
33 mycobacterium tuberculosis 1 9.8
34 human immunodeficiency virus type 1 9.8
35 pemphigus vulgaris 9.8
36 sacrococcygeal teratoma 9.8
37 ulcerative colitis 9.8
38 colitis 9.8
39 keratomalacia 9.8
40 leiomyoma 9.8
41 acute cystitis 9.8
42 squamous cell papilloma 9.8
43 schistosomiasis 9.8
44 lymphangioma 9.8
45 ectropion 9.8
46 cystitis 9.8
47 cervicitis 9.8
48 papilloma 9.8
49 endometriosis 9.8
50 teratoma 9.8

Graphical network of the top 20 diseases related to Vaginal Discharge:



Diseases related to Vaginal Discharge

Symptoms & Phenotypes for Vaginal Discharge

Drugs & Therapeutics for Vaginal Discharge

Drugs for Vaginal Discharge (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 132)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Metronidazole Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 443-48-1 4173
2
Iodine Approved, Investigational Phase 4,Phase 3 7553-56-2 807
3
Povidone Approved Phase 4,Phase 3 9003-39-8
4
Povidone-iodine Approved Phase 4,Phase 3 25655-41-8
5
Chlorhexidine Approved, Vet_approved Phase 4,Phase 3 55-56-1 2713 9552079
6
Clotrimazole Approved, Vet_approved Phase 4,Phase 3 23593-75-1 2812
7
Clindamycin Approved, Vet_approved Phase 4,Phase 3 18323-44-9 29029
8
Secnidazole Approved Phase 4,Phase 3 3366-95-8
9
Polyestradiol phosphate Approved Phase 4,Phase 3,Phase 2,Not Applicable 28014-46-2
10
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 50-28-2 5757
11
Chlorquinaldol Approved Phase 4 72-80-0
12 Anti-Infective Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
13 Antiparasitic Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
14 Antiprotozoal Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
15 Anti-Bacterial Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
16 Hormones Phase 4,Phase 3,Phase 2,Not Applicable
17 Hormone Antagonists Phase 4,Phase 3,Phase 2,Not Applicable
18 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Not Applicable
19 Anti-Infective Agents, Local Phase 4,Phase 3
20 Micronutrients Phase 4,Phase 3,Not Applicable
21 Nutrients Phase 4,Phase 3,Not Applicable
22 Dermatologic Agents Phase 4,Phase 3
23 Plasma Substitutes Phase 4,Phase 3
24 Blood Substitutes Phase 4,Phase 3
25 Chlorhexidine gluconate Phase 4,Phase 3
26 Disinfectants Phase 4,Phase 3
27 Pharmaceutical Solutions Phase 4,Phase 2,Phase 3
28 Trace Elements Phase 4,Phase 3,Not Applicable
29 cadexomer iodine Phase 4,Phase 3
30 Clindamycin palmitate Phase 4,Phase 3
31 Clindamycin phosphate Phase 4,Phase 3
32 Estrogens Phase 4,Phase 3,Phase 2,Not Applicable
33 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
34 Acidophilus Phase 4,Phase 2
35 Estradiol 3-benzoate Phase 4,Phase 3,Phase 2,Not Applicable
36 Estradiol 17 beta-cypionate Phase 4,Phase 3,Phase 2,Not Applicable
37 Estrogens, Conjugated (USP) Phase 4
38
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 2 22916-47-8 4189
39
Fluconazole Approved, Investigational Phase 3 86386-73-4 3365
40
Tinidazole Approved, Investigational Phase 3 19387-91-8 5479
41
Nystatin Approved, Vet_approved Phase 3 1400-61-9 11953884
42
Neomycin Approved, Vet_approved Phase 3 1404-04-2 8378
43
Polymyxin B Approved, Vet_approved Phase 3 1404-26-8
44
Aluminum sulfate Approved Phase 3 10043-01-3
45
Fluocinolone Acetonide Approved, Investigational, Vet_approved Phase 3 67-73-2 6215
46
Terconazole Approved Phase 3 67915-31-5 441383
47
Exemestane Approved, Investigational Phase 3 107868-30-4 60198
48
Tamoxifen Approved Phase 3,Phase 2 10540-29-1 2733526
49
Progesterone Approved, Vet_approved Phase 2, Phase 3,Not Applicable 57-83-0 5994
50
Imiquimod Approved, Investigational Phase 3 99011-02-6 57469

Interventional clinical trials:

(show top 50) (show all 100)
# Name Status NCT ID Phase Drugs
1 The Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP) Unknown status NCT02629510 Phase 4 Tachosil
2 Tolerance of Chlorhexidine Gluconate Vaginal Cleansing Solution Completed NCT03305159 Phase 4 Povidone-Iodine;4% Chlorhexidine Gluconate
3 Examining the Impact of Tampon Use on the Vaginal Microbiota Completed NCT03346759 Phase 4
4 Safety and Tolerability of Metronidazole Gel 1.3% Completed NCT02392026 Phase 4 Metronidazole Gel
5 Comparison of Two Topical Formulations Containing Clindamycin and Clotrimazole in Patients With Vaginal Infections Completed NCT01697826 Phase 4 ClinSupV3 -soft gelatin capsule;ClinSupV3ER- Extended release tablet
6 Postmenopausal Pessary Users: Estrogen Versus Trimosan Recruiting NCT03943823 Phase 4 Estrogen vaginal cream;Trimo-San vaginal gel
7 Treatment Comparison of Antibiotics Versus Vaginal Lactic Acid in Non-pregnant Women With Acute Symptomatic Bacterial Vaginosis Recruiting NCT02042287 Phase 4 Metronidazole
8 Evaluate the Safety of a Single Oral Dose of Solosec™ (Secnidazole) 2g for the Treatment of Adolescent Girls With BV Recruiting NCT03937869 Phase 4 Secnidazole
9 Probiotics as Adjuvant Treatment for Bacterial Vaginosis Recruiting NCT03894813 Phase 4 "Probiotics" and "Metronidazole";Metronidazole Vaginal
10 Surgical Intervention With DermaPure vs Native Tissue in Pelvic Organ Prolapse Not yet recruiting NCT03939715 Phase 4
11 Colposeptine for the Treatment of Bacterial Vaginosis Terminated NCT01153958 Phase 4 Colposeptine;Metronidazole
12 A Pilot Open-label Randomized Study of Lactofiltrum in Women With Bacterial Vaginosis Unknown status NCT01089348 Phase 2, Phase 3 Lactofiltrum + Metronidazole;Metronidazole
13 Safety and Clinical and Microbiological Efficacy of the Combination of Fluconazole and Secnidazole for the Treatment of Symptomatic Vaginal Discharge Completed NCT02111629 Phase 3 Fluconazole and Secnidazole
14 Study of the Management of Vaginal Discharge in West African Using Single Dose Treatments Completed NCT00313131 Phase 3 tinidazole+fluconazole vs metronidazole+clotrimazole
15 Assessment of the Efficacy of POLYGYNAX® in the Empirical Treatment of Infectious Vaginitis Completed NCT02515656 Phase 3 POLYGYNAX®;GYNODAKTARIN®;Placebo
16 A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant Women Completed NCT02210689 Phase 3 clindamycin phosphate vaginal cream 2%
17 The Value of Bacterial Loads by Real Time PCR in Predicting Recurrence of Abnormal Vaginal Flora After Oral Metronidazole Therapy Completed NCT01287728 Phase 3 Treatment BY METROMIDAZOLE
18 Efficacy and Safety of Clino-san on Vaginal Dryness of Breast Cancer Patients Completed NCT00607295 Phase 3 clino-san vaginal lubricant
19 Diabetes Mellitus and Vulvovaginal Candidiasis Completed NCT00353561 Phase 3 Boric;Fluconazole
20 HerpeVac Trial for Young Women Completed NCT00057330 Phase 3
21 A Phase 3 Study of SYM-1219 Treatment of Women and Post-Menarchal Adolescent Girls With Bacterial Vaginosis Completed NCT02418845 Phase 3 SYM-1219;Placebo
22 A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious Vaginosis Completed NCT01867164 Phase 3 Gynoclin V;Vagitrol V
23 Pessary in Singleton Gestations With Short Cervix Without Prior Preterm Birth Completed NCT02716909 Phase 3
24 Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer Completed NCT00038467 Phase 3 Tamoxifen;Exemestane
25 The Study Of Fluconazole For Vulvovaginal Candidiasis Completed NCT01806623 Phase 3 Fluconazole
26 Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV) Completed NCT02237950 Phase 3 Metronidazole oral tablets 500mg;1% SPL7013 Gel;Placebo gel
27 Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV) Completed NCT02236156 Phase 3 Metronidazole oral tablets 500mg;1% SPL7013 Gel;Placebo gel
28 A Phase 3 Study of Solosec® for the Treatment of Trichomoniasis Recruiting NCT03935217 Phase 3 Secnidazole;Placebo
29 Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study Protocol Recruiting NCT02669459 Phase 3 Imiquimod
30 Does a Rescue Course of Betamethasone in Pregnant Women With PPROM Decrease Neonatal Morbidity? Recruiting NCT02939742 Phase 2, Phase 3 Betamethasone;Placebo
31 Pre-delivery Administration of Azithromycin to Prevent Neonatal Sepsis & Death Recruiting NCT03199547 Phase 3 Azithromycin;Placebo Oral Tablet
32 Ketoconazole Gel Versus Terconazole Cream for Vaginal Candidiasis Not yet recruiting NCT03473418 Phase 3 Ketoconazole;Terconazole
33 Cervical Pessary vs Vaginal Progesterone in Preventing Preterm Birth Among Women Presenting With Short Cervix: An Open-label Randomized Controlled Trial Not yet recruiting NCT02470676 Phase 2, Phase 3 Progesterone
34 Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring and Levonorgestrel-Ethinyl Estradiol Combined Oral Contraceptive in Adult Women at Risk for Pregnancy (MK-8342B-062) Terminated NCT02616146 Phase 3 ENG-E2 125 μg/300 μg vaginal ring;LNG-EE 150 μg/30 μg COC
35 A Comparison of Surgical Preparations and Wound Infection Rates for Elective Cesarean Sections Terminated NCT00528008 Phase 3
36 Efficacy and Safety of the Association of Clotrimazole and Metronidazole in the Treatment of Vaginal Discharge From Different Etiologies. Withdrawn NCT02713139 Phase 3 Clotrimazole + Metronidazole;Metronidazole;Clotrimazole
37 Efficacy, Safety LactiSal 1% Gel, LactSal 50 mg, Clotrimazole 100 mg Tablet in Treatment Vulvovaginal Candidiasis Withdrawn NCT02907307 Phase 3 Clotrimazole vaginal tablet 100mg
38 Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infection Completed NCT00305227 Phase 2 Lactin-V;Placebo
39 Metronidazole for Pulmonary Tuberculosis (South Korea) Completed NCT00425113 Phase 2 Metronidazole
40 A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis Completed NCT02147899 Phase 2 SYM-1219;Placebo
41 Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis Completed NCT02709005 Phase 2 5% Monolaurin Vaginal Gel
42 Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis Completed NCT01055106 Phase 2 GW05;GW05;GW05;Metronidazole
43 Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery Completed NCT02225353 Phase 2 Progesterone Cervical Pessary 6.3 g;Progesterone 200 mg vaginal capsules;Progesterone Cervical Pessary 7.7 g
44 Tactile Electrosurgical Ablation in Cases of Dysfunctional Uterine Bleeding Completed NCT02248194 Phase 2
45 Randomized, Open-label Phase 2 Study of Oral AZD0914 in the Treatment of Gonorrhea Completed NCT02257918 Phase 2 AZD0914;Ceftriaxone
46 CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis Recruiting NCT02629419 Phase 2 Amphotericin B
47 Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast Recruiting NCT02993159 Phase 2 Afimoxifene;Tamoxifen Citrate
48 Vaginal Creams to Reduce Vaginal Erosion in Pessary Users Withdrawn NCT02316249 Phase 2 Estradiol
49 The Treatment Effect of Chinese Herbal Compound Ointment on Atrophic Vaginitis Unknown status NCT02733731 Phase 1 Chinese Herbal Compound Ointment;Estriol
50 Treatment of Bacterial Vaginosis Prior to Active Labor and Infectious Morbidity Not yet recruiting NCT03954990 Phase 1 Metronidazole Oral;Placebo Oral Tablet

Search NIH Clinical Center for Vaginal Discharge

Cochrane evidence based reviews: vaginal discharge

Genetic Tests for Vaginal Discharge

Anatomical Context for Vaginal Discharge

MalaCards organs/tissues related to Vaginal Discharge:

42
Cervix, Testes, Skin, Uterus, Kidney, Breast

Publications for Vaginal Discharge

Articles related to Vaginal Discharge:

(show top 50) (show all 351)
# Title Authors Year
1
Description of Janibacter massiliensis sp. nov., cultured from the vaginal discharge of a patient with bacterial vaginosis. ( 30798490 )
2019
2
Risk factors associated with reproductive performance in Japanese dairy cows: Vaginal discharge with flecks of pus or calving abnormality extend time to pregnancy. ( 30473578 )
2019
3
Accuracy of leukocyte esterase test, endometrial cytology and vaginal discharge score for diagnosing postpartum reproductive tract health status in dairy cows at the moment of sampling, using a latent class model fit within a Bayesian framework. ( 30621886 )
2019
4
Draft Genome Sequence of Listeria monocytogenes CIIMS-NV-3, a Strain Isolated from Vaginal Discharge of a Woman from Central India. ( 30746522 )
2019
5
A Study of Trichomonas vaginalis Infection and Correlates in Women with Vaginal Discharge Referred at Fann Teaching Hospital in Senegal. ( 31057956 )
2019
6
Syndromic management of sexually transmissible infections in resource-poor settings: a systematic review with meta-analysis of the abnormal vaginal discharge flowchart for Neisseria gonorrhoea and Chlamydia trachomatis. ( 28838352 )
2018
7
Definitive Management of Persistent Vaginal Discharge Caused by Leiomyoma-endometrial Fistulas after Uterine Artery Embolization. ( 29223699 )
2018
8
Sacrococcygeal Teratoma Presenting with Vaginal Discharge and Polyp in an Infant. ( 29269272 )
2018
9
Vaginal discharge concentrations of β-human chorionic gonadotropin, creatinine, and urea for the diagnosis of premature rupture of membranes. ( 29197087 )
2018
10
Response of lactating dairy cows with or without purulent vaginal discharge to gonadotropin-releasing hormone and prostaglandin F2α. ( 29385599 )
2018
11
The Etiology of Vaginal Discharge Syndrome in Zimbabwe: Results from the Zimbabwe STI Etiology Study. ( 29465674 )
2018
12
Vaginal Discharge in a Pre-pubertal Girl Posing a Diagnostic Challenge. ( 29872604 )
2018
13
2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. ( 30049258 )
2018
14
Relationship of vaginal discharge characteristics evaluated by Metricheck device to metabolic status in postpartum dairy cows. ( 30051632 )
2018
15
Chronic Vaginal Discharge After Uterine Fibroid Embolization. ( 30146213 )
2018
16
Randomized clinical trial to evaluate the efficacy of prostaglandin F2α to treat purulent vaginal discharge in lactating dairy cows. ( 30292549 )
2018
17
The demographic and clinical profiles of women presenting with vaginal discharge syndrome at primary care facilities in South Africa: Associations with age and implications for management. ( 30421718 )
2018
18
Tuberculosis of the cervix: An uncommon cause of vaginal discharge in a post-menopausal woman. ( 31044761 )
2018
19
Effect of diagnosis and treatment of clinical endometritis based on vaginal discharge score grading system in postpartum Holstein cows. ( 28740032 )
2017
20
Effectiveness of intrauterine treatment with cephapirin in dairy cows with purulent vaginal discharge. ( 28043367 )
2017
21
Application of a bacteriological on-farm test to reduce antimicrobial usage in dairy cows with purulent vaginal discharge. ( 28237589 )
2017
22
Genetic and functional analysis of the bovine uterine microbiota. Part II: Purulent vaginal discharge versus healthy cows. ( 28259411 )
2017
23
Purulent vaginal discharge in grazing dairy cows: Risk factors, reproductive performance, and prostaglandin F2α treatment. ( 28318582 )
2017
24
Effects of intrauterine infusion of Escherichia coli lipopolysaccharide on uterine mRNA gene expression and peripheral polymorphonuclear leukocytes in Jersey cows diagnosed with purulent vaginal discharge. ( 28434729 )
2017
25
Effects of intrauterine infusion of Escherichia coli lipopolysaccharide on uterine health, resolution of purulent vaginal discharge, and reproductive performance of lactating dairy cows. ( 28434752 )
2017
26
Epidemiology and clinico-investigative study of organisms causing vaginal discharge. ( 28442807 )
2017
27
An Insight to How Estate Women in Sri Lanka Manage Abnormal Vaginal Discharge. ( 28451566 )
2017
28
Cervical cytopathological changes among women with vaginal discharge attending teaching hospital. ( 28469316 )
2017
29
Primary chylous vaginal discharge demonstrated with noncontrast magnetic resonance lymphography. ( 28475249 )
2017
30
Trichomonas vaginalis is very rare among women with vaginal discharge in Podlaskie province, Poland. ( 28612378 )
2017
31
Consider the Risk of Vesicouterine Fistula in the Event of Intermittent Fluid Vaginal Discharge after a Cesarean Section. ( 29090213 )
2017
32
Efficacy of Tamarindus indicus, Melia azadirach and Santalum album in syndromic management of abnormal vaginal discharge: A single-blind randomised controlled trial. ( 29257757 )
2017
33
Effect of Vaginal Hygiene Module to Attitudes and Behavior of Pathological Vaginal Discharge Prevention Among Female Adolescents in Slemanregency, Yogyakarta, Indonesia. ( 29282418 )
2017
34
Effects of rumen-protected methionine and choline supplementation on vaginal discharge and uterine cytology of Holstein cows. ( 30255041 )
2017
35
Variables associated with vaginal discharge after ultrasound-guided percutaneous microwave ablation for adenomyosis. ( 27087631 )
2016
36
High Risk Human Papilloma Virus Genotypes in Kurdistan Region in Patients with Vaginal Discharge. ( 27509950 )
2016
37
Chylocolporrhea or chylous vaginal discharge: diagnostic conundrum with therapeutic challenge. ( 26386963 )
2016
38
Co-infection with Bovine Herpesvirus 4 and Histophilus somni Significantly Extends the Service Period in Dairy Cattle with Purulent Vaginal Discharge. ( 26690881 )
2016
39
Do female patients with nonpathological vaginal discharge need the same evaluation as for Dhat syndrome in males? ( 26985107 )
2016
40
Efficacy of syndromic management measured as symptomatic improvement in females with vaginal discharge syndrome. ( 27190409 )
2016
41
Sore throat · vaginal discharge · labial ulcer · Dx? ( 27474821 )
2016
42
Study to Evaluate Targeted Management and Syndromic Management in Women Presenting with Abnormal Vaginal Discharge. ( 27651658 )
2016
43
The Performance of the Vaginal Discharge Syndromic Management in Treating Vaginal and Cervical Infection: A Systematic Review and Meta-Analysis. ( 27706174 )
2016
44
Utility of Laboratory Diagnosis for Confirmation of the Syndromic Case Management in Married Indian Women with Vaginal Discharge. ( 27833516 )
2016
45
Low-Grade Appendiceal Mucinous Neoplasm Involving the Endometrium and Presenting with Mucinous Vaginal Discharge. ( 27843660 )
2016
46
Primary care management of women with persistent vaginal discharge. ( 27861272 )
2016
47
Prepubertal vaginal discharge: Vaginoscopy to rule out foreign body. ( 27976557 )
2016
48
Profuse Vaginal Discharge May Equally Suggest Adenoma Malignum and Lobular Endocervical Glandular Hyperplasia (LEGH), But Same Cover, Different Story. ( 27678817 )
2015
49
Randomized clinical trial of intrauterine cephapirin infusion in dairy cows for the treatment of purulent vaginal discharge and cytological endometritis. ( 26210270 )
2015
50
Determination of optimal diagnostic criteria for purulent vaginal discharge and cytological endometritis in dairy cows. ( 26210278 )
2015

Variations for Vaginal Discharge

Expression for Vaginal Discharge

Search GEO for disease gene expression data for Vaginal Discharge.

Pathways for Vaginal Discharge

GO Terms for Vaginal Discharge

Biological processes related to Vaginal Discharge according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cellular response to hormone stimulus GO:0032870 8.62 DSPP PGF

Sources for Vaginal Discharge

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....